Logo image of MBOT

MICROBOT MEDICAL INC (MBOT) Stock Fundamental Analysis

NASDAQ:MBOT - Nasdaq - US59503A2042 - Common Stock - Currency: USD

2.55  +0.02 (+0.79%)

After market: 2.5399 -0.01 (-0.4%)

Fundamental Rating

3

Overall MBOT gets a fundamental rating of 3 out of 10. We evaluated MBOT against 187 industry peers in the Health Care Equipment & Supplies industry. MBOT has a great financial health rating, but its profitability evaluates not so good. MBOT has a expensive valuation and it also scores bad on growth.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

MBOT had negative earnings in the past year.
In the past year MBOT has reported a negative cash flow from operations.
MBOT had negative earnings in each of the past 5 years.
In the past 5 years MBOT always reported negative operating cash flow.
MBOT Yearly Net Income VS EBIT VS OCF VS FCFMBOT Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 -2M -4M -6M -8M -10M

1.2 Ratios

MBOT's Return On Assets of -37.79% is on the low side compared to the rest of the industry. MBOT is outperformed by 62.57% of its industry peers.
MBOT has a Return On Equity (-40.32%) which is comparable to the rest of the industry.
Industry RankSector Rank
ROA -37.79%
ROE -40.32%
ROIC N/A
ROA(3y)-152.25%
ROA(5y)-111.82%
ROE(3y)-247.81%
ROE(5y)-171.96%
ROIC(3y)N/A
ROIC(5y)N/A
MBOT Yearly ROA, ROE, ROICMBOT Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 500 -500 1K 1.5K

1.3 Margins

MBOT does not have Profit Margin and Operating Margin and Gross Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
MBOT Yearly Profit, Operating, Gross MarginsMBOT Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024

More info and screens

8

2. Health

2.1 Basic Checks

Compared to 1 year ago, MBOT has more shares outstanding
Compared to 5 years ago, MBOT has more shares outstanding
MBOT has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
MBOT Yearly Shares OutstandingMBOT Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M
MBOT Yearly Total Debt VS Total AssetsMBOT Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M

2.2 Solvency

An Altman-Z score of 25.67 indicates that MBOT is not in any danger for bankruptcy at the moment.
The Altman-Z score of MBOT (25.67) is better than 97.33% of its industry peers.
MBOT has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z 25.67
ROIC/WACCN/A
WACCN/A
MBOT Yearly LT Debt VS Equity VS FCFMBOT Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10M -10M 20M 30M

2.3 Liquidity

MBOT has a Current Ratio of 16.19. This indicates that MBOT is financially healthy and has no problem in meeting its short term obligations.
MBOT has a Current ratio of 16.19. This is amongst the best in the industry. MBOT outperforms 96.79% of its industry peers.
A Quick Ratio of 16.19 indicates that MBOT has no problem at all paying its short term obligations.
MBOT's Quick ratio of 16.19 is amongst the best of the industry. MBOT outperforms 97.86% of its industry peers.
Industry RankSector Rank
Current Ratio 16.19
Quick Ratio 16.19
MBOT Yearly Current Assets VS Current LiabilitesMBOT Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M

More info and screens

1

3. Growth

3.1 Past

MBOT shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 17.50%, which is quite good.
EPS 1Y (TTM)17.5%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%47.06%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

MBOT is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 29.73% yearly.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next Y55.89%
EPS Next 2Y29.73%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
MBOT Yearly Revenue VS EstimatesMBOT Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2025 2026 5M 10M 15M
MBOT Yearly EPS VS EstimatesMBOT Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 -200 -400 -600 -800

More info and screens

1

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for MBOT. In the last year negative earnings were reported.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for MBOT. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
MBOT Price Earnings VS Forward Price EarningsMBOT Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 40 60

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
MBOT Per share dataMBOT EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.5 -0.5

4.3 Compensation for Growth

A more expensive valuation may be justified as MBOT's earnings are expected to grow with 29.73% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y29.73%
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

MBOT does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

MICROBOT MEDICAL INC

NASDAQ:MBOT (8/1/2025, 8:00:00 PM)

After market: 2.5399 -0.01 (-0.4%)

2.55

+0.02 (+0.79%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)05-14 2025-05-14/amc
Earnings (Next)08-12 2025-08-12
Inst Owners6.52%
Inst Owner Change-0.03%
Ins Owners1.47%
Ins Owner Change0%
Market Cap97.38M
Analysts82.86
Price Target9.18 (260%)
Short Float %20.84%
Short Ratio4.55
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)11.6%
Min EPS beat(2)-8.93%
Max EPS beat(2)32.13%
EPS beat(4)2
Avg EPS beat(4)2.45%
Min EPS beat(4)-15.34%
Max EPS beat(4)32.13%
EPS beat(8)6
Avg EPS beat(8)10.46%
EPS beat(12)9
Avg EPS beat(12)9.9%
EPS beat(16)11
Avg EPS beat(16)4.66%
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)0%
EPS NQ rev (3m)33.33%
EPS NY rev (1m)0%
EPS NY rev (3m)20%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)-50%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S N/A
P/FCF N/A
P/OCF N/A
P/B 3.36
P/tB 3.36
EV/EBITDA N/A
EPS(TTM)-0.66
EYN/A
EPS(NY)-0.23
Fwd EYN/A
FCF(TTM)-0.24
FCFYN/A
OCF(TTM)-0.24
OCFYN/A
SpS0
BVpS0.76
TBVpS0.76
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -37.79%
ROE -40.32%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-152.25%
ROA(5y)-111.82%
ROE(3y)-247.81%
ROE(5y)-171.96%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score6
Asset Turnover0
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 30.77%
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 16.19
Quick Ratio 16.19
Altman-Z 25.67
F-Score6
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)46.2%
Cap/Depr(5y)70.94%
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)17.5%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%47.06%
EPS Next Y55.89%
EPS Next 2Y29.73%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-31.68%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y21.14%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y20.95%
OCF growth 3YN/A
OCF growth 5YN/A